U.S. Packaging Stock News

Avnet stock jumped 5.1% to US$97.22 after earnings, a sharp move for a company often treated as a steady, low‑drama electronics distributor. The market is reacting to one thing above all: the quarter capped FY 2026 with record quarterly sales of US$8.3b and record adjusted earnings per share of US$2.28, which is a powerful finish for a business that lives on thin component margins. Coming into this print, Avnet shares had already logged double digit gains over the past month. Today’s reaction...

Syndax Pharmaceuticals stock closed up 4.4% at US$19.92, a sharp move for a company that came into this week with a slightly negative 30 day return and a soft 90 day run. The headline today is simple: Q2 revenue reached US$72.8m with Revuforj and Niktimvo together delivering US$115m in quarterly commercial sales, and management reiterated that the balance sheet is funded to support late stage programs. Short term traders are reacting to the bounce. Long term investors are likely focused on...

Ascent Industries stock inched up 1.3% to US$15.58 into the first full trading day after earnings, a muted move for a quarter that flipped the income statement from losses to a profit. Q2 basic earnings per share landed at US$0.07 with net sales of US$25.7 million, while adjusted earnings before interest, tax, depreciation and amortization turned positive. The short term reaction looks restrained given that shift. The bigger question now is whether this first profitable quarter in a while...

Owens Corning stock jumped 4.8% to US$152.47 the day after earnings, a confident move for a building products company that has been wrestling with losses over the past year. On the surface, the headline is simple. Q2 2026 delivered about US$2.8b of revenue and adjusted earnings power, with adjusted EBITDA at US$660m and a 24% margin. The key question is how that profitability compares with a still unprofitable trailing twelve months and a valuation that already trades a touch above a...

Recursion Pharmaceuticals stock has struggled over the long haul, with a steep five year share price decline set against valuation checks that still do not mark it out as a clear bargain today. Over the past five years, Recursion Pharmaceuticals has fallen about 87.9%, which puts the current US$3.17 share price in the context of a long period of weak returns for shareholders. Recent collaboration progress with Genentech can support confidence in Recursion Pharmaceuticals' drug discovery...

Essential Utilities came into this earnings print with a stock that has barely moved, up just 0.08% to US$39.59, even after the numbers hit. For a regulated utility often treated as a steady compounder, that flat reaction sits against a quarter where net income of US$105.7 million on US$530.9 million of revenue kept the earnings engine humming. The focus is not the quarterly noise. More notable is that trailing net profit margin now sits at 21.6% while the stock trades on roughly 20.2x...

8x8 stock inched up 3.1% to US$2.31 heading into the first full trading session after earnings, which is a calm move for results that reshaped the profit story. The headline is simple. A communications and contact center platform that spent years in the red just put up Q1 non GAAP operating income of US$18.9m on US$190.2m of revenue and did it while usage driven business expanded sharply. The market is treating that as a routine beat. The numbers suggest a deeper rethink of what this business...

The market cheered BlueLinx Holdings on the open, sending the stock up about 13% to US$72.54, even though this is still a distributor that has been unprofitable over the last year. The headline from Q2 is simple: BlueLinx put real profit back on the board with US$814.1m in net sales and US$0.82 in basic earnings per share, helped by firmer margins in both specialty and structural products. For a stock often framed as a low P/S turnaround story, this quarter’s clean swing to positive earnings...

Emerson Electric stock edged up 2.3% to US$162.47 in the first full session after earnings, a measured move for a company often treated as a steady industrial compounder. The results told a stronger story than that modest price reaction suggests. Adjusted earnings per share reached US$1.71 and free cash flow hit US$1.3b in the quarter, helped by a 140 basis point lift in segment EBITDA margin to 28.5%. For investors, the key takeaway is that profitability is doing the heavy lifting for...

1stdibs.Com stock jumped 12.8% to US$4.93 the day after earnings, which suggests traders reacted positively in the near term. The market is reacting to one thing above all else: margin repair is starting to show up in the numbers. Revenue for the quarter came in at US$23.3 million while the company still reported a loss, with basic earnings per share of about US$0.03. The short term story is about improving unit economics and adjusted profitability. The bigger question for you is how long...

ePlus stock handed back 2.6% today to about US$94.56 after investors weighed a solid but unspectacular quarter against a valuation that already prices in a lot of good news. The key issue is margin pressure. Net sales reached US$649.1m and bookings and open orders moved higher, yet gross margin slipped to 23.3% and earnings per share landed at US$1.16 on a GAAP basis. Short term traders see a stock cooling after a strong run over the past month. Longer term investors are now asking whether...

Space Exploration Technologies stock came into this earnings season already under pressure, with the share price down about 28% over the past month. The Q2 print then triggered a sharper reassessment, with the stock dropping another 13.6% to US$108.27 by the close on August 5. The surprise is that the headline story is not revenue disappointment. SpaceX posted US$7.8b in Q2 revenue and adjusted earnings before interest, tax, depreciation and amortization of US$3.5b, while still reporting a...

In late July 2026, Manhattan Associates reported second-quarter results showing higher revenue but lower net income and earnings per share, issued full-year 2026 guidance, completed a long-running US$1,641.56 million buyback program, and subsequently filed a US$572.91 million shelf registration for 3,000,000 ESOP-related common shares. The combination of revenue growth alongside earnings pressure, fresh guidance and a shift from completed repurchases toward potential new share issuance...

With tariffs being imposed, refunded and challenged in court all at once, global logistics and freight stocks sit directly in the crosshairs of policy and trade flows. Those rapid US$100b refund payments and new 10% to 12.5% duties are shaking up balance sheets and shipping routes, which can create both beneficiaries and bystanders. This article looks at 3 stocks exposed to these tariff shifts and explains why investors are watching them now. The 3 stocks below are just a starting sample, and...

The market hit the sell button on Super Group today. The stock closed at US$13.11, down almost 6% on the session and weaker over the past month, even after a World Cup fueled report that showed Q2 revenue of US$684m and net income of US$120m. That clash between a softer share price and a richer profit print is the core story. Traders appear focused on short term worries, while the earnings release put the spotlight on a higher adjusted EBITDA margin and a company that reported another record...

Jacobs Solutions stock barely moved after earnings, rising about 1% to roughly US$145, even though the quarter delivered numbers investors usually notice. The company reported adjusted earnings per share of US$1.84, with adjusted net revenue growth above 8% and an adjusted earnings before interest, tax, depreciation and amortisation margin of 15.2%. For a long term infrastructure and advanced facilities story, the key highlight is the record US$29b backlog and a book to bill ratio above 1x,...

MarketAxess Holdings (MKTX) is back in focus after Intercontinental Exchange agreed to acquire the company for approximately US$6 billion in cash at US$167 per share, representing a 33% premium to the prior closing price. See our latest analysis for MarketAxess Holdings. The takeover news has triggered a sharp shift in MarketAxess Holdings’ share price momentum. A 7 day share price return of 29.17% and 30 day share price return of 39.48% stand in contrast to a year to date share price decline...

New York Times stock just absorbed a shock. Shares closed down about 13% to US$65.48, capping a tough stretch that already had the stock falling over the past week, month and quarter. The emotional read is simple: investors saw the drop and treated this as a setback. The earnings story is more complicated. Q2 revenue reached about US$762 million and net income was roughly US$93 million, supported by a clear push in digital subscriptions and advertising. The market is punishing the stock while...

Versigent stock slipped 1.7% to about US$45 in the first full session after Q2 earnings, even though the headline story was margin strength. The company turned US$2.4b of net sales into US$272m of adjusted earnings before interest, taxes, depreciation and amortisation, with an 11.1% adjusted EBITDA margin and 120 basis points of expansion year on year. For a stock already trading on a P/E near 6x and sitting well below analyst discounted cash flow estimates, that kind of margin progress is...

Cipher Digital (NasdaqGS:CIFR) reported progress on its data center buildout, including delivering capacity ahead of schedule and beginning rent collection. The company secured a US$810m funding package to support current and planned projects. Cipher Digital announced a new large data center site, expanding its development pipeline. Regulatory scrutiny in Texas increased after the Governor initiated a review that could affect project timelines. Cipher Digital operates data centers that...

Azenta walked into this earnings season with a turnaround label and a stock that had already climbed over the past quarter. The 5.6% jump to US$31.82 after the Q3 print shows investors liked what they saw. The tension is simple: the company still reports losses on a trailing basis, yet this quarter delivered US$161.2m of revenue and positive non GAAP earnings per share of US$0.16. That mix of improving income metrics and ongoing red ink is the real story behind today’s upbeat price...

Pfizer stock has rebounded over the past year after a weak few years, yet the broader valuation checks and current market multiples still suggest the shares are not a clear bargain at today’s price. The stock has fallen 27.4% over the past 5 years, which means long term holders have yet to fully recover despite the recent improvement. Recent product news and new trial results can support confidence in future cash flows, while concerns about patent expirations and integration of recent...

OneSpan stock barely moved after its Q2 print, with the share price edging up only 0.6% even though the company put a clear spotlight on profitability. The headline is simple. Subscription driven cybersecurity and digital agreements revenue supported adjusted EBITDA of US$16.9 million at a 28% margin. For a software and security platform, that level of earnings quality is what matters most today. The market’s muted reaction sits at odds with that profit story. Investors appear more focused on...

Icahn Enterprises dropped about 3.5% to US$7.46 into the close, yet the real story sits behind that modest price move. The headline is another loss on the bottom line. Q2 net income attributable to common holders came in at a loss of US$348m, or US$0.52 per unit, even as revenue reached US$2.98b. For a stock already trading around 0.5x sales and below an estimated fair value of US$8.44, the market now has to weigh fresh operating losses against a balance sheet that still relies on high...